Outcomes associated with comorbid atrial fibrillation and heart failure in medicare beneficiaries with acute coronary syndrome

BMC Health Services Research

Jeff Schein¹  Luke Boulanger²  Michael Stokes²  Concetta Crivera¹  Shih-Yin Chen² 

[1] Janssen Scientific Affairs, LLC, 1000 Route 202, Raritan, NJ, USA;Evidera, 430 Bedford Street Suite 300, Lexington, MA 02420, USA

关键词: Medicare;    Heart failure;    Coronary disease;    Atrial fibrillation;   

Others  :  1134069
DOI  :  10.1186/1472-6963-14-80

 received in 2013-03-20, accepted in 2014-01-07,  发布年份 2014

【 摘 要 】

Background

Atrial fibrillation (AF) and heart failure (HF) are both common comorbid conditions of elderly patients with acute coronary syndrome (ACS), but published data on their associated clinical and economic outcomes are limited.

Methods

Our study included patients from the Medicare Current Beneficiary Survey with an incident hospitalization for ACS between 03/01/2002 and 12/31/2006. Applying population weights, we identified 795 incident ACS patients, representing more than 2.5 million Medicare beneficiaries. Of this population, 13.1% had comorbid AF, and 22.9% had HF, which were identified from Medicare claims during the 6 months prior to the first ACS event (index date) Subsequent cardiovascular (CV) hospitalizations and mortality were compared using Kaplan–Meier curves. Cox proportional hazards regressions were used to estimate the relative risk of AF and HF on CV events and mortality. Healthcare costs were summarized for the calendar year in which the incident ACS event occurred.

Results

HF was associated with a 41% higher risk of mortality (HR = 1.41; 95% confidence interval [CI] 1.05–1.89). Both AF (HR = 1.46; 95% CI 1.14–1.87) and HF (HR = 1.61; 95% CI 1.26–2.06) were associated with higher risks of subsequent CV events. During the year of the incident ACS event, ACS patients with comorbid AF or HF had approximately $18,000 higher total healthcare costs than those without these comorbidities.

Conclusion

Using a nationally representative sample of Medicare beneficiaries, we observed a significantly higher clinical and economic burden of patients hospitalized for ACS with comorbid AF and HF compared with those without these conditions.

【 授权许可】

   
2014 Chen et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

【 参考文献 】

• [1]Roger VL, Go AS, Lloyd-Jones DM, Benjamin EJ, Berry JD, Borden WB, Bravata DM, Dai S, Ford ES, Fox CS, Fullerton HJ, Gillespie C, Hailpern SM, Heit JA, Howard VJ, Kissela BM, Kittner SJ, Lackland DT, Lichtman JH, Lisabeth LD, Makuc DM, Marcus GM, Marelli A, Matchar DB, Moy CS, Mozaffarian D, Mussolino ME, Nichol G, Paynter NP, Soliman EZ, Sorlie PD, Sotoodehnia N, Turan TN, Virani SS, Wong ND, Woo D, Turner MB: Heart disease and stroke statistics—2012 update: a report from the American Heart Association. Circulation 2012, 125:e2-e220.
• [2]Kolansky DM: Acute coronary syndromes: morbidity, mortality, and pharmacoeconomic burden. Am J Manag Care 2009, 15:S36-S41.
• [3]Ehrlich JR, Nattel S, Hohnloser SH: Atrial fibrillation and congestive heart failure: specific considerations at the intersection of two common and important cardiac disease sets. J Cardiovasc Electrophysiol 2002, 13:399-405.
• [4]Lau DH, Alasady M, Brooks AG, Sanders P: New-onset atrial fibrillation and acute coronary syndrome. Expert Rev Cardiovasc Ther 2010, 8:941-948.
• [5]Wang TJ, Larson MG, Levy D, Vasan RS, Leip EP, Wolf PA, D’Agostino RB, Murabito JM, Kannel WB, Benjamin EJ: Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham heart study. Circulation 2003, 107:2920-2925.
• [6]Go AS, Hylek EM, Phillips KA, Chang Y, Henault LE, Selby JV, Singer DE: Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study. JAMA 2001, 285:2370-2375.
• [7]Lakshminarayan K, Solid CA, Collins AJ, Anderson DC, Herzog CA: Atrial fibrillation and stroke in the general Medicare population: a 10-year perspective (1992 to 2002). Stroke 2006, 37:1969-1974.
• [8]Miyasaka Y, Barnes ME, Gersh BJ, Cha SS, Bailey KR, Abhayaratna WP, Seward JB, Tsang TS: Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence. Circulation 2006, 114:119-125.
• [9]Kim MH, Johnston SS, Chu BC, Dalal MR, Schulman KL: Estimation of total incremental health care costs in patients with atrial fibrillation in the United States. Circ Cardiovasc Qual Outcomes 2011, 4:313-320.
• [10]Heidenreich PA, Trogdon JG, Khavjou OA, Butler J, Dracup K, Ezekowitz MD, Finkelstein EA, Hong Y, Johnston SC, Khera A, Lloyd-Jones DM, Nelson SA, Nichol G, Orenstein D, Wilson PW, Woo YJ: Forecasting the future of cardiovascular disease in the united states: a policy statement from the American Heart Association. Circulation 2011, 123:933-944.
• [11]Lau DH, Huynh LT, Chew DP, Astley CM, Soman A, Sanders P: Prognostic impact of types of atrial fibrillation in acute coronary syndromes. Am J Cardiol 2009, 104:1317-1323.
• [12]Lopes RD, Pieper KS, Horton JR, Al-Khatib SM, Newby LK, Mehta RH, Van de Werf F, Armstrong PW, Mahaffey KW, Harrington RA, Ohman EM, White HD, Wallentin L, Granger CB: Short- and long-term outcomes following atrial fibrillation in patients with acute coronary syndromes with or without ST-segment elevation. Heart 2008, 94:867-873.
• [13]Torres M, Rocha S, Marques J, Nabais S, Rebelo A, Pereira MA, Azevedo P, Correia A: Impact of atrial fibrillation in acute coronary syndromes. Rev Port Cardiol 2008, 27:1407-1418.
• [14]Steg PG, Dabbous OH, Feldman LJ, Cohen-Solal A, Aumont MC, Lopez-Sendon J, Budaj A, Goldberg RJ, Klein W, Anderson FA Jr: Determinants and prognostic impact of heart failure complicating acute coronary syndromes: observations from the Global Registry of Acute Coronary Events (GRACE). Circulation 2004, 109:494-499.
• [15]Steg PG, Goldberg RJ, Gore JM, Fox KA, Eagle KA, Flather MD, Sadiq I, Kasper R, Rushton-Mellor SK, Anderson FA, GRACE Investigators: Baseline characteristics, management practices, and in-hospital outcomes of patients hospitalized with acute coronary syndromes in the Global Registry of Acute Coronary Events (GRACE). Am J Cardiol 2002, 90:358-363.
• [16]Adler GS: A profile of the medicare current beneficiary survey. Health Care Financ Rev 1994, 15:153-163.
• [17]D’Hoore W, Bouckaert A, Tilquin C: Practical considerations on the use of the charlson comorbidity index with administrative data bases. J Clin Epidemiol 1996, 49:1429-1433.
• [18]Mihaylova B, Briggs A, O’Hagan A, Thompson SG: Review of statistical methods for analysing healthcare resources and costs. Health Econ 2011, 20:897-916.
• [19]Roe MT, Chen AY, Riba AL, Goswami RG, Peacock WF, Pollack CV Jr, Collins SP, Gibler WB, Ohman EM, Peterson ED: Impact of congestive heart failure in patients with non-st-segment elevation acute coronary syndromes. Am J Cardiol 2006, 97:1707-1712.
• [20]Amin AN, Jhaveri M, Lin J: Incremental cost burden to us healthcare payers of atrial fibrillation/atrial flutter patients with additional risk factors. Adv Ther 2011, 28:907-926.
• [21]Lee WC, Lamas GA, Balu S, Spalding J, Wang Q, Pashos CL: Direct treatment cost of atrial fibrillation in the elderly American population: a Medicare perspective. J Med Econ 2008, 11:281-298.
• [22]Unroe KT, Greiner MA, Hernandez AF, Whellan DJ, Kaul P, Schulman KA, Peterson ED, Curtis LH: Resource use in the last 6 months of life among Medicare beneficiaries with heart failure, 2000–2007. Arch Intern Med 2011, 171:196-203.
• [23]Whellan DJ, Greiner MA, Schulman KA, Curtis LH: Costs of inpatient care among Medicare beneficiaries with heart failure, 2001 to 2004. Circ Cardiovasc Qual Outcomes 2010, 3:33-40.